Sei Investments CO Cara Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$16.11 - $25.98 $277,236 - $447,089	-17,209 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$18.28 - $26.91 $314,580 - $463,094	17,209 New	17,209 $315,000
Q3 2018 Nov 08, 2018	SELL	$17.57 - $23.95 $2,196 - $2,993	-125 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$11.86 - $14.08 $1,482 - $1,760	125	125 $2,000

16.5M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.